Table 1.
Demographics of the study population
| PD (N = 96) |
Control (N = 74) |
Total (N = 170) |
|
|---|---|---|---|
| Race | |||
| White | 78 (81.3%) | 58 (78.4%) | 136 (80.0%) |
| Latino | 18 (18.8%) | 16 (21.6%) | 34 (20.0%) |
| Sex | |||
| Male | 64 (66.7%) | 25 (33.8%) | 89 (52.4%) |
| Female | 32 (33.3%) | 49 (66.2%) | 81 (47.6%) |
| Age | |||
| Mean (SD) | 72.9 (9.17) | 69.7 (8.61) | 71.5 (9.04) |
| Median [Min, Max] | 73.5 [43.0, 95.0] | 69.5 [44.0, 88.0] | 71.5 [43.0, 95.0] |
| Platform | |||
| HiSeq | 81 (84.4%) | 56 (75.7%) | 137 (80.6%) |
| MiSeq | 15 (15.6%) | 18 (24.3%) | 33 (19.4%) |
| Duration of PD Diagnosis | |||
| Mean (SD) | 9.6 (4.3) | ||
| Median [Min, Max] | 9 [3, 20] | ||
| Missing | 3 | ||
| Motor subtype | |||
| PIGD | 44 (47.3%) | ||
| Tremor Dominant and Indeterminate | 49 (52.7%) | ||
| Missing | 3 | ||
| LEDD | |||
| Mean (SD) | 563 (495) | ||
| Median [Min, Max] | 450 [0, 2190] | ||
| Missing | 3 | ||
| UPDRS III Score | |||
| Mean (SD) | 28.7 (13.4) | ||
| Median [Min, Max] | 29.0 [5.00, 66.2] | ||
| Missing | 3 |
PD, Parkinson’s disease; PIGD, postural instability and gait dysfunction; LEDD, levodopa equivalent doses; UPDRS, Unified Parkinson’s Disease Rating Scale.